| LAG 3 (CD 223) as a cancer immunotherapy target LP Andrews, AE Marciscano, CG Drake, DAA Vignali Immunological reviews 276 (1), 80-96, 2017 | 818 | 2017 |
| Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma L Chen, J Douglass, L Kleinberg, X Ye, AE Marciscano, PM Forde, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 916-925, 2018 | 301 | 2018 |
| Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β ME Hardee, AE Marciscano, CM Medina-Ramirez, D Zagzag, A Narayana, ... Cancer research 72 (16), 4119-4129, 2012 | 273 | 2012 |
| Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy AE Marciscano, A Ghasemzadeh, TR Nirschl, D Theodros, CM Kochel, ... Clinical Cancer Research 24 (20), 5058-5071, 2018 | 237 | 2018 |
| Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment Y Muroyama, TR Nirschl, CM Kochel, Z Lopez-Bujanda, D Theodros, ... Cancer immunology research 5 (11), 992-1004, 2017 | 178 | 2017 |
| White paper on microbial anti-cancer therapy and prevention NS Forbes, RS Coffin, L Deng, L Evgin, S Fiering, M Giacalone, ... Journal for immunotherapy of cancer 6, 1-24, 2018 | 125 | 2018 |
| Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade WL Hwang, AE Marciscano, A Niemierko, DW Kim, ... Neuro-oncology 18 (6), 863-872, 2016 | 125 | 2016 |
| Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes AE Marciscano, AO Stemmer-Rachamimov, A Niemierko, M Larvie, ... Journal of neurosurgery 124 (1), 106-114, 2016 | 115 | 2016 |
| The role of dendritic cells in cancer and anti-tumor immunity AE Marciscano, N Anandasabapathy Seminars in immunology 52, 101481, 2021 | 113 | 2021 |
| TNFα and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors BJ Francica, A Ghasemzadeh, AL Desbien, D Theodros, KE Sivick, ... Cancer immunology research 6 (4), 422-433, 2018 | 72 | 2018 |
| Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities AE Marciscano, A Haimovitz-Friedman, P Lee, PT Tran, WA Tomé, ... International Journal of Radiation Oncology* Biology* Physics 110 (1), 35-52, 2021 | 62 | 2021 |
| Radiation therapy and the in situ vaccination approach EB Golden, AE Marciscano, SC Formenti International Journal of Radiation Oncology* Biology* Physics 108 (4), 891-898, 2020 | 49 | 2020 |
| Stereotactic body radiation therapy in pancreatic cancer: the new frontier S Moningi, AE Marciscano, LM Rosati, SK Ng, R Teboh Forbang, ... Expert review of anticancer therapy 14 (12), 1461-1475, 2014 | 36 | 2014 |
| Role of noninvasive molecular imaging in determining response AE Marciscano, DLJ Thorek Advances in Radiation Oncology 3 (4), 534-547, 2018 | 26 | 2018 |
| Long-term treatment response and patient outcomes for vestibular schwannoma patients treated with hypofractionated stereotactic radiotherapy MA Patel, AE Marciscano, C Hu, I Jusué-Torres, R Garg, A Rashid, ... Frontiers in Oncology 7, 200, 2017 | 24 | 2017 |
| Incorporating radiation oncology into immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop AE Marciscano, JM Walker, HM McGee, MM Kim, CA Kunos, ... Journal for immunotherapy of cancer 6, 1-8, 2018 | 22 | 2018 |
| Introduction to the medical professions through an innovative medical student-run pipeline program N Nair, AE Marciscano, KL Vivar, S Schaeffer, E LaMont, F Francois Journal of the National Medical Association 103 (9-10), 832-838, 2011 | 18 | 2011 |
| Is there a role for an external beam boost in cervical cancer radiotherapy? RA Sethi, G Jozsef, D Grew, A Marciscano, R Pennell, M Babcock, ... Frontiers in Oncology 3, 3, 2013 | 17 | 2013 |
| Management of high-risk localized prostate cancer AE Marciscano, ME Hardee, N Sanfilippo Advances in urology 2012, 2011 | 17 | 2011 |
| 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma T Schneider, J Chapiro, M Lin, JF Geschwind, L Kleinberg, D Rigamonti, ... European radiology 26, 849-857, 2016 | 16 | 2016 |
